Compare AIRS & MRLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIRS | MRLN |
|---|---|---|
| Founded | 2012 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.4M | 172.8M |
| IPO Year | 2021 | 2024 |
| Metric | AIRS | MRLN |
|---|---|---|
| Price | $1.23 | $0.87 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $4.50 | ★ $7.92 |
| AVG Volume (30 Days) | 853.8K | ★ 2.9M |
| Earning Date | 11-06-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $151,818,000.00 | N/A |
| Revenue This Year | N/A | $9.23 |
| Revenue Next Year | $2.65 | $153.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.15 | $0.82 |
| 52 Week High | $12.00 | $17.00 |
| Indicator | AIRS | MRLN |
|---|---|---|
| Relative Strength Index (RSI) | 24.35 | 21.73 |
| Support Level | N/A | N/A |
| Resistance Level | $3.31 | $3.45 |
| Average True Range (ATR) | 0.12 | 0.12 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 8.00 | 7.48 |
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
Merlin Inc develops software that fulfills the functions of a human pilot in self-flying aircraft to enable both reduced crew and unmanned flight. This technology is designed to be scalable and adaptable across different aircraft types for a growing range of aircraft platforms. The company's aircraft-agnostic, AI-powered software is purpose-built for military and civil programs, and is powering an expanding range of missions and aircraft, through hundreds of autonomous flights from test facilities across the globe. It operates as a single operating and reportable segment.